Bioprosthetics Market, By Product (Allograft and Xenograft), By Application, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4309
|
Published Date
August 2025
|
Pages
311
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Bioprosthetics Market size was valued at US$ 5,948 Million in 2024, expanding at a CAGR of 4.80% from 2025 to 2032.
Bioprosthetics involve the use of biological materials in the creation of prosthetic devices designed to replace or restore the function of damaged or missing body parts. Unlike traditional prosthetics, which are typically made from synthetic materials such as plastics or metals, bioprosthetics incorporate natural tissues or biomaterials to more closely replicate the structure and function of human body parts.
Bioprosthetics Market- Market Dynamics
Advancements in regenerative medicine techniques
Rapid advancements in regenerative medicine are fueling innovation in bioprosthetics, especially through stem cell therapy and tissue engineering. These cuttingedge techniques enable the development of bioprosthetic devices that closely mimic natural tissues, enhancing integration, functionality, and longterm patient outcomes. For instance, in October 2024, researchers successfully applied stem cellderived therapies to treat agerelated macular degeneration, significantly improving patients’ vision. This breakthrough highlights the potential of regenerative approaches to restore function and elevate quality of life. Globally, government investment in regenerative medicine is surging. In the United States, federal funding for regenerative therapies reached approximately USD5.2billion in 2023, with an additional USD1.3billion allocated through Medicaid—underscoring substantial public-sector support.
In the AsiaPacific region, India’s Department of Biotechnology committed USD181million to stem cell research under the National Biopharma Mission, while South Korea and Australia are similarly boosting funding and infrastructure. These public investments, combined with private and philanthropic funding, are accelerating the commercialization of regenerative therapies. As regenerative medicine continues to evolve, this robust government backing is expected to enhance the performance, durability, and accessibility of bioprosthetic implants—thereby driving both clinical advances and market growth.
Bioprosthetics Market- Segmentation Analysis:
The Global Bioprosthetics Market is segmented on the basis of Product, Application, and Region.
The bioprosthetics market is segmented by product into Allograft and Xenograft, with the allograft segment projected to dominate the market in 2025. This dominance can be attributed to the growing geriatric population and ongoing advancements in allograft procedures. An allograft refers to a tissue or organ transplant between individuals of the same species, offering significant benefits in terms of implant survival and functional outcomes. As the global population continues to age, the prevalence of cardiovascular diseases (CVD) rises, necessitating more tissue repair procedures. Allografts, such as Artivion, Inc.\'s CryoValve AORTIC ALLOGRAFT, which includes a complete aortic root and the attached anterior mitral leaflet, offer diverse surgical implantation options that improve clinical outcomes. According to the World Health Organization (WHO), the global population aged 60 years and older is expected to double by 2050, reaching over 2 billion, thereby significantly increasing the demand for bioprosthetic solutions.
When categorized by application, the market is divided into Cardiovascular and Plastic Surgery & Wound Healing, with the plastic surgery and wound healing segment projected to witness the fastest growth during the forecast period. This growth is driven by the rising demand for minimally invasive procedures and rapid technological advancements in surgical methods. According to the American Society of Plastic Surgeons (ASPS), cosmetic procedures among men increased by 6%, while overall cosmetic surgery procedures have grown by 5% annually. The adoption of less invasive techniques is further enhancing patient recovery outcomes, fueling segment expansion. Complementing this trend, data from the U.S. Food and Drug Administration (FDA) shows a notable rise in approved medical devices for soft tissue repair and aesthetic procedures, reflecting the government’s support for innovation in minimally invasive technologies.
Bioprosthetics Market- Geographical Insights
From a geographical standpoint, North America is expected to lead the global bioprosthetics market in 2025. This regional growth is fueled by high rates of cardiovascular disease, the presence of well-established healthcare infrastructure, and increasing healthcare expenditure. The Centers for Disease Control and Prevention (CDC) reports that in the United States, one person dies every 33 seconds from cardiovascular disease, underlining the urgent need for advanced bioprosthetic heart valves and cardiovascular solutions. The U.S. contributes significantly to this regional dominance, thanks to the presence of major biopharma companies, favorable reimbursement frameworks, and substantial investments in research and development. According to the National Institutes of Health (NIH), the U.S. allocated over $45 billion to medical research funding in 2024, with a notable portion directed toward cardiovascular and regenerative medicine, further boosting innovation and market growth.
The Asia Pacific region is expected to have the fastest CAGR during the forecast period. This rapid growth is driven by increased awareness of alternative treatments, rapidly developing healthcare infrastructure, and increased engagement in research and development in developing countries like India and China. Government initiatives in these countries aim to improve healthcare accessibility and quality, which supports regional growth potential. China\'s Healthy China 2030 plan aims to improve health and promote longevity. This may lead to increased adoption of advanced medical technologies, such as bioprosthetics.
Bioprosthetics Market- Competitive Landscape:
The bioprosthetics market is highly competitive, driven by continuous technological advancements, innovative materials, and a growing demand for minimally invasive procedures. Leading companies such as LeMaitre Vascular, Inc., Braile Biomédica, Medtronic, Rua Life Sciences Plc (formerly Aortech International Plc), and LivaNova PLC (formerly Sorin Group) dominate the market with a broad range of bioprosthetic heart valves and vascular grafts. These companies maintain their competitive edge by investing heavily in research and development, pursuing strategic acquisitions, and expanding their global footprint.
At the same time, emerging companies and startups are entering the market with cutting-edge tissue-engineered implants and personalized bioprosthetic solutions. The increasing adoption of transcatheter aortic valve replacement (TAVR), along with favorable regulatory approvals and the rising prevalence of cardiovascular and orthopedic conditions, is intensifying competition and accelerating innovation within the industry.
Recent Development:
- In December 2024, Indian medical device manufacturer Meril Life Sciences introduced the Myval Octapro transcatheter heart valve (THV), which received CE mark approval for use in TAVR procedures. This marks a significant milestone for the company and highlights the growing global presence of innovative bioprosthetic solutions.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BIOPROSTHETICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- LeMaitre Vascular, Inc.
- Braile Biomédica
- Medtronic
- Rua Life Sciences Plc (Aortech International Plc.)
- LivaNova PLC (Sorin Group)
- Organogenesis Inc.
- Labcor Laboratories Ltda.
- Humacyte Global, Inc.
- Johnson & Johnson (Ethicon, Inc.)
- Abbott (St. Jude Medical, Inc.)
- Artivion, Inc. (CryoLife, Inc.)
- Edwards Lifesciences Corporation.
- JenaValve
- Others
GLOBAL BIOPROSTHETICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032
- Allograft
- Xenograft
GLOBAL BIOPROSTHETICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Cardiovascular
- Plastic surgery & wound healing
GLOBAL BIOPROSTHETICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Bioprosthetics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Bioprosthetics Market Snippet by Product
2.1.2. Bioprosthetics Market Snippet by Application
2.1.3. Bioprosthetics Market Snippet by Country
2.1.4. Bioprosthetics Market Snippet by Region
2.2. Competitive Insights
3. Bioprosthetics Key Market Trends
3.1. Bioprosthetics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Bioprosthetics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Bioprosthetics Market Opportunities
3.4. Bioprosthetics Market Future Trends
4. Bioprosthetics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Bioprosthetics Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Bioprosthetics Market Landscape
6.1. Bioprosthetics Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Bioprosthetics Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
7.1.2. Allograft
7.1.3. Xenograft
8. Bioprosthetics Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
8.1.2. Cardiovascular
8.1.3. Plastic surgery & wound healing
9. Bioprosthetics Market– By Geography
9.1. Introduction
9.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
9.2. North America
9.2.1. Overview
9.2.2. Bioprosthetics Key Manufacturers in North America
9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.2.6. U.S.
9.2.6.1. Overview
9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.2.6.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.2.6.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.2.7. Canada
9.2.7.1. Overview
9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.2.7.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.2.7.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.3. Europe
9.3.1. Overview
9.3.2. Bioprosthetics Key Manufacturers in Europe
9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.3.6. Germany
9.3.6.1. Overview
9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.6.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.3.6.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.3.7. UK
9.3.7.1. Overview
9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.7.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.3.7.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.3.8. France
9.3.8.1. Overview
9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.8.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.3.8.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.3.9. Italy
9.3.9.1. Overview
9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.3.9.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.3.10. Spain
9.3.10.1. Overview
9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.10.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.3.10.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.3.11. The Netherlands
9.3.11.1. Overview
9.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.11.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.3.11.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.3.12. Sweden
9.3.12.1. Overview
9.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.12.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.3.12.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.3.13. Russia
9.3.13.1. Overview
9.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.13.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.3.13.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.3.14. Poland
9.3.14.1. Overview
9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.14.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.3.15. Rest of Europe
9.3.15.1. Overview
9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.4. Asia Pacific (APAC)
9.4.1. Overview
9.4.2. Bioprosthetics Key Manufacturers in Asia Pacific
9.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.4.6. China
9.4.6.1. Overview
9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.6.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.4.6.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.4.7. India
9.4.7.1. Overview
9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.4.8. Japan
9.4.8.1. Overview
9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.8.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.4.8.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.4.9. South Korea
9.4.9.1. Overview
9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.9.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.4.9.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.4.10. Australia
9.4.10.1. Overview
9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.10.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.4.10.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.4.11. Indonesia
9.4.11.1. Overview
9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.11.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.4.11.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.4.12. Thailand
9.4.12.1. Overview
9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.4.13. Philippines
9.4.13.1. Overview
9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.13.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.4.13.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.4.14. Rest of APAC
9.4.14.1. Overview
9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.14.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.5. Latin America (LATAM)
9.5.1. Overview
9.5.2. Bioprosthetics Key Manufacturers in Latin America
9.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.5.6. Brazil
9.5.6.1. Overview
9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.6.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.5.6.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.5.7. Mexico
9.5.7.1. Overview
9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.7.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.5.7.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.5.8. Argentina
9.5.8.1. Overview
9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.8.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.5.8.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.5.9. Colombia
9.5.9.1. Overview
9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.9.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.5.9.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.5.10. Rest of LATAM
9.5.10.1. Overview
9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.10.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.6. Middle East and Africa (MEA)
9.6.1. Overview
9.6.2. Bioprosthetics Key Manufacturers in Middle East and Africa
9.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.6.6. Saudi Arabia
9.6.6.1. Overview
9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.6.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.6.7. UAE
9.6.7.1. Overview
9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.7.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.6.7.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.6.8. Israel
9.6.8.1. Overview
9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.8.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.6.8.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.6.9. Turkey
9.6.9.1. Overview
9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.9.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.6.9.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.6.10. Algeria
9.6.10.1. Overview
9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.10.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.6.10.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.6.11. Egypt
9.6.11.1. Overview
9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.11.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.6.11.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.6.12. Rest of MEA
9.6.12.1. Overview
9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.12.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10. Key Vendor Analysis- Bioprosthetics Industry
10.1. Competitive Benchmarking
10.1.1. Competitive Dashboard
10.1.2. Competitive Positioning
10.2. Company Profiles
10.2.1. LeMaitre Vascular, Inc.
10.2.2. Braile Biomédica
10.2.3. Medtronic
10.2.4. Rua Life Sciences Plc (Aortech International Plc.)
10.2.5. LivaNova PLC (Sorin Group)
10.2.6. Organogenesis Inc.
10.2.7. Labcor Laboratories Ltda.
10.2.8. Humacyte Global, Inc.
10.2.9. Johnson & Johnson (Ethicon, Inc.)
10.2.10. Abbott (St. Jude Medical, Inc.)
10.2.11. Artivion, Inc. (CryoLife, Inc.)
10.2.12. Edwards Lifesciences Corporation.
10.2.13. JenaValve
10.2.14. Others
11. 360 Degree AnalystView
12. Appendix
12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
